Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.
Bernstein DI, Aoki FY, Tyring SK, Stanberry LR, St-Pierre C, Shafran SD, Leroux-Roels G, Van Herck K, Bollaerts A, Dubin G; GlaxoSmithKline Herpes Vaccine Study Group.
Bernstein DI, et al. Among authors: stanberry lr.
Clin Infect Dis. 2005 May 1;40(9):1271-81. doi: 10.1086/429240. Epub 2005 Mar 24.
Clin Infect Dis. 2005.
PMID: 15825029
Clinical Trial.